Semnur Pharmaceuticals, Inc.
SMNR----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Semnur Pharmaceuticals, Inc.(SMNR) the EBIT is -4.224 M (-322.8%);the EPS is -0.0189 (-278%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B322.82%
----
----
EPS
-0.0189278.02%
----
----
Upcoming earnings report - Q3 FY2026
Available dateNov 11, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly